1. Home
  2. DMRC vs MXCT Comparison

DMRC vs MXCT Comparison

Compare DMRC & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digimarc Corporation

DMRC

Digimarc Corporation

HOLD

Current Price

$6.83

Market Cap

172.8M

Sector

Technology

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.61

Market Cap

160.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRC
MXCT
Founded
2008
1999
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.8M
160.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DMRC
MXCT
Price
$6.83
$1.61
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$20.00
$7.50
AVG Volume (30 Days)
172.1K
1.4M
Earning Date
10-30-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,663,000.00
$34,419,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.63
$10.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.35
$1.26
52 Week High
$48.32
$5.20

Technical Indicators

Market Signals
Indicator
DMRC
MXCT
Relative Strength Index (RSI) 34.65 53.02
Support Level $6.51 $1.48
Resistance Level $8.61 $1.65
Average True Range (ATR) 0.58 0.08
MACD -0.18 0.01
Stochastic Oscillator 8.15 78.38

Price Performance

Historical Comparison
DMRC
MXCT

About DMRC Digimarc Corporation

Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: